Ranzenhofer Honors Roswell Park CEO Johnson at State Capitol Ceremony

Roswell Park Cancer Institute’s President & CEO Dr. Candace S. Johnson has joined other prominent New York women– including Susan B. Anthony, Lucille Ball and Harriet Tubman– as one of the newest inductees of the Women of Distinction program.  

She is the first female leader of the 118-year-old comprehensive cancer center, holding the Wallace Family Chair in Translational Research, and also serving as Professor of Oncology.  

Dr. Johnson joined the faculty of Roswell Park Cancer Institute in February 2002, and is currently the Institute’s 15th President and CEO.  Prior to that, she was Deputy Director of the Institute and also Chair of the Department of Pharmacology and Therapeutics. Her major responsibilities were to facilitate the seamless bench-to-bedside development and delivery of promising new cancer therapies.

Dr. Johnson earned her doctoral degree in Immunology from Ohio State University, Columbus. She completed research and postdoctoral fellowships in Immunology/Cell Biology at the Michigan Cancer Foundation, Detroit.

###